Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer’s β-Amyloid
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
β-Amyloid (Aβ) fibrillogenesis is closely associated with the pathogenesis of Alzheimer’s disease (AD), so detection and inhibition of Aβ aggregation are of significance for the theranostics of AD. In this work, the coassembled nanoparticles of chitosan and hyaluronic acid cross-linked with glutaraldehyde (CHG NPs) were found to work as a theranostic agent for imaging/probing and inhibition of Aβ fibrillization both in vitro and in vivo. The biomass-based CHG NPs of high stability exhibited a wide range of excitation/emission wavelengths and showed binding affinity toward Aβ aggregates, especially for soluble Aβ oligomers. CHG NPs displayed weak emission in the monodispersed state, while they remarkably emitted increased red fluorescence upon interacting with Aβ oligomers and fibrils, showing high sensitivity with a detection limit of 0.1 nM. By comparing the different fluorescence responses of CHG NPs and Thioflavin T to Aβ aggregation, the Aβ oligomerization rate during nucleation can be determined. Moreover, the fluorescence recognition behavior of CHG NPs was selective. CHG NPs specifically bind to negatively charged amyloid aggregates but not to positively charged amyloids and negatively charged soluble proteins. Such enhancement in fluorescence emission is attributed to the clustering-triggered emission effect of CHG NPs after interaction with Aβ aggregates via various electronic conjugations and hydrogen bonding, electrostatic, and hydrophobic interactions. Besides fluorescent imaging/probing, CHG NPs over 360 μg/mL could almost completely inhibit the formation of Aβ fibrils, exhibiting the capability of regulating Aβ aggregation. In-vivo assays with Caenorhabditis elegans CL2006 demonstrated the potency of CHG NPs as an effective theranostic nanoagent for imaging Aβ plaques and inhibiting Aβ deposition. The findings proved the potential of CHG NPs for development as a potent agent for the diagnosis and treatment of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The authors measured the dissociation constants for chitosan–hyaluronic acid Nps (CHG NPs) and showed that the affinity for oligomers (Kd = 5.0 μg/mL) is slightly higher than for fibrils (Kd = 6.2 μg/mL).”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [68]
In the citing paper
“CHG NPs detect oligomers already after 3 h of incubation, while the ThT signal, reflecting fibril formation, only begins to increase after 14.6 h”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [68]
In the citing paper
“they possess their own stable fluorescence, which eliminates the need for additional diagnostic labels [68,84]”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [68]
In the citing paper
“Fluorescence imaging is most frequently used [68,77,79,84], due to the simplicity of implementation and the high sensitivity of the method, allowing the detection of pathological aggregates both in vitro and in small animals.”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [68]
In the citing paper
“The most common approach is the inhibition of Aβ aggregation and the disaggregation of already formed fibrils [29,68,77,79,81,84].”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [68]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652
Aggregation‐Induced Emission: New Vistas at the Aggregate Level
Zhao, Z., Zhang, H., Lam, J. W. Y., & Tang, B. Z. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916729 · Cited by 1,428
Aggregation-induced emission: fundamental understanding and future developments
Chen, Y., Lam, J. W. Y., Kwok, R. T. K., Liu, B., & Tang, B. Z. (2019) · Materials Horizons · doi:10.1039/c8mh01331d · Cited by 891
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
Musiek, E. S., & Holtzman, D. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4018 · Cited by 662
Groenning, M. (2010) · Journal of Chemical Biology · doi:10.1007/s12154-009-0027-5 · Cited by 643
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Fu, W., Yan, C., Guo, Z., Zhang, J., Zhang, H., Tian, H., & Zhu, W.-H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b12820 · Cited by 444
Cited by
La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74
Ghosh, S., Sachdeva, B., Sachdeva, P., Chaudhary, V., Rani, G. M., & Sinha, J. K. (2022) · Carbon letters · doi:10.1007/s42823-022-00397-9 · Cited by 75
Wang, W., Lin, X., Dong, X., & Sun, Y. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.06.029 · Cited by 53
Self-citationWang, L., Zhou, F., & Xie, W. (2025) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-025-06946-8 · Cited by 50
“Furthermore, CHG NPs ef fi ciently inhibited A β fi bril formation and were con fi rmed in vivo in Caenorhabditis [150].”
Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis
Li, L., He, R., Yan, H., Leng, Z., Zhu, S., & Gu, Z. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101654 · Cited by 50
Metadata
- Authors
- Wang, W., Liu, M., Gao, W., Sun, Y., & Dong, X.
- Affiliations
- Tianjin University (CN)
- Corresponding author
- Sun, Yan
- Dong, Xiaoyan
- Venue
- ACS Applied Materials & Interfaces
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-11-17
- Volume
- 13
- Issue
- 47
- Pages
- 55879-55889
- ISSN
- 1944-8244 (ISSN-L)
- 1944-8252
- OpenAlex
- W3214648236
- Cited by
- 53
- References
- 57
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 9
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Applied Materials & Interfaces (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tianjin Science and Technology Committee (19JCZDJC36800)
- National Natural Science Foundation of China (21621004, 21978207)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
- Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
- Keywords
- amyloid-beta, Alzheimer's disease, theranostics, amyloid fibril formation, amyloid oligomers, fluorescence imaging, glutaraldehyde crosslinking, amyloid aggregation inhibition, Caenorhabditis elegans, nucleation rate
- MeSH terms
- Theranostic Nanomedicine, Alzheimer Disease, Animals, Anti-Bacterial Agents, Biocompatible Materials, Fluorescence, Humans, Hyaluronic Acid, Microbial Sensitivity Tests, Particle Size, Surface Properties, Amyloid beta-Peptides, Caenorhabditis elegans, Cell Line, Tumor, Chitosan, Nanoparticles, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer’s β-Amyloid. https://app.cochat.ai/papers/10.1021/acsami.1c17267
- The paper
- Wang, W., Liu, M., Gao, W., Sun, Y., & Dong, X. (2021). Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer’s β-Amyloid. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.1c17267
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.